clenbuterol has been researched along with Muscle Disorders in 6 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol (CB), a selective β2-adrenergic receptor (AR) agonist, induces muscle hypertrophy and counteracts muscle atrophy." | 3.83 | Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol. ( Cai, W; Fujita, T; Ishikawa, Y; Ito, A; Jin, H; Kawamura, N; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Saeki, Y; Shiozawa, K; Suita, K; Umeki, D; Yagisawa, Y, 2016) |
| "Clenbuterol is a β2 -adrenergic receptor agonist known to induce skeletal muscle hypertrophy and a slow-to-fast phenotypic shift." | 3.81 | Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery. ( Bonnieu, A; Candau, RB; Cazorla, O; Chopard, A; Douillard, A; Galbès, O; Lacampagne, A; Lionne, C; Philippe, AG; Py, G; Ramonatxo, C; Sanchez, AM; Sirvent, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Py, G | 1 |
| Ramonatxo, C | 1 |
| Sirvent, P | 1 |
| Sanchez, AM | 1 |
| Philippe, AG | 1 |
| Douillard, A | 1 |
| Galbès, O | 1 |
| Lionne, C | 1 |
| Bonnieu, A | 1 |
| Chopard, A | 1 |
| Cazorla, O | 1 |
| Lacampagne, A | 1 |
| Candau, RB | 1 |
| Ohnuki, Y | 1 |
| Umeki, D | 1 |
| Mototani, Y | 1 |
| Shiozawa, K | 1 |
| Nariyama, M | 1 |
| Ito, A | 1 |
| Kawamura, N | 1 |
| Yagisawa, Y | 1 |
| Jin, H | 1 |
| Cai, W | 1 |
| Suita, K | 1 |
| Saeki, Y | 1 |
| Fujita, T | 1 |
| Ishikawa, Y | 1 |
| Okumura, S | 1 |
| Woodall, BP | 1 |
| Woodall, MC | 1 |
| Luongo, TS | 1 |
| Grisanti, LA | 1 |
| Tilley, DG | 1 |
| Elrod, JW | 1 |
| Koch, WJ | 1 |
| Desaphy, JF | 1 |
| Pierno, S | 1 |
| De Luca, A | 1 |
| Didonna, P | 1 |
| Camerino, DC | 1 |
| Shi, H | 1 |
| Zeng, C | 1 |
| Ricome, A | 1 |
| Hannon, KM | 1 |
| Grant, AL | 1 |
| Gerrard, DE | 1 |
| Costelli, P | 1 |
| García-Martínez, C | 1 |
| Llovera, M | 1 |
| Carbó, N | 1 |
| López-Soriano, FJ | 1 |
| Agell, N | 1 |
| Tessitore, L | 1 |
| Baccino, FM | 1 |
| Argilés, JM | 1 |
6 other studies available for clenbuterol and Muscle Disorders
| Article | Year |
|---|---|
Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
Topics: Action Potentials; Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Calcium; Clenbutero | 2015 |
Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene E | 2016 |
Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.
Topics: Animals; Clenbuterol; G-Protein-Coupled Receptor Kinase 2; Hypertrophy; Mice; Mice, Knockout; Muscle | 2016 |
Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Clenbuterol; Humans; Musc | 2003 |
Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.
Topics: Adrenergic beta-Agonists; Animals; Cell Cycle Proteins; Cell Line; Clenbuterol; Disease Models, Anim | 2007 |
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Ascites; Clenbuterol; Corticosterone; Hypertr | 1995 |